Tekla Life Sciences Investors ( HQL) - Stock Earnings
HQL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 50.3 million USD | -225192 USD |
| 2023Q4 | 25.1 million USD | 1.0 million USD |
| 2023Q3 | -11.5 million USD | 29.6 million USD |
| 2023Q1 | 33.8 million USD | 9.8 million USD |
| 2022Q4 | 16901 USD | 964 USD |
HQL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 22.4 million USD | 23.5 million USD |
| 2022 | -104.6 million USD | -103.3 million USD |
| 2021 | 64.5 million USD | 65.7 million USD |
| 2020 | 123.1 million USD | 124.1 million USD |
| 2019 | -70.5 million USD | -69.3 million USD |
HQL
Price: $12.85
Forward Dividend Yield: 13.39%
Payout Ratio: 146.27%
Dividend Per Share: 1.72 USD
Earnings Per Share: 3.04 USD
P/E Ratio: 4.18
Exchange: NYQ
Sector: Financial Services
Industry: Asset Management
Volume: 93486
Market Capitalization: 366.5 million
Average Dividend Frequency: 4
Years Paying Dividends: 30
DGR3: -2.15%
DGR5: 0.60%
DGR10: 0.22%
DGR20: 20.88%